Why is Jenburkt Pharma falling/rising?

As of 04-Jul, Jenburkt Pharmaceuticals Ltd. is experiencing a price increase, with its current price at Rs 1,377.75, reflecting a rise of Rs 18.0 or 1.32%. The stock has shown strong performance, with a 5.17% increase over the past week and a remarkable 56.85% gain over the last year, significantly outperforming the BSE500 index during the same period. Today's price action indicates that the stock is close to its 52-week high, just 2.05% away, and it has outperformed its sector by 0.81%. Additionally, the stock is trading above all key moving averages, and there has been a notable increase in investor participation, with delivery volume rising by 47.63% compared to the five-day average.
In the broader market context, while the Sensex has declined by 0.74% over the past week, Jenburkt Pharmaceuticals has managed to deliver positive returns, highlighting its resilience and strong market position. The company's low debt-to-equity ratio and consistent market-beating performance over both the long and short term further support its upward price movement. Overall, the combination of strong recent performance, positive investor sentiment, and favorable market conditions contributes to the stock's rising price.